Patents Assigned to Entarco SA
  • Patent number: 8697661
    Abstract: The present invention relates to the use of spinosyns and spinosyn compositions as pharmaceuticals and methods for treatment—including prevention—of protozoan infections and/or disorders relating to a protozoan infection, such as malaria and leishmania, viral infections such as Herpes Simplex virus and Influenza virus and neoplastic disorders or cancer. Advantageously, compositions of the invention inhibit protozoan, virus growth and neoplastic cell proliferation with only minimal or no disruption or harm to the host which may be an animal or human.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: April 15, 2014
    Assignees: Entarco SA
    Inventor: Christine Kritikou
  • Publication number: 20130228096
    Abstract: Disclosed herein are antifouling compositions including at least one spinosyn active material. These compositions provide protection to surfaces coated or impregnated therewith from attachment of various biofouling organisms. Compositions include, for example, paint, varnish, and sealant formulations.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 5, 2013
    Applicant: Entarco SA
    Inventor: Christine Kritikou
  • Publication number: 20130195790
    Abstract: Disclosed herein are antifouling compositions including at least one spinosyn active material. These compositions provide protection to surfaces coated or impregnated therewith from attachment of various biofouling organisms. Compositions include, for example, paint, varnish, and sealant formulations.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicants: Entarco SA
    Inventors: Entarco SA, Chistine Kritikou
  • Publication number: 20120195961
    Abstract: The present invention relates to the use of spinosyns and spinosyn compositions as pharmaceuticals and methods for treatment—including prevention—of protozoan infections and/or disorders relating to a protozoan infection, such as malaria and leishmania, viral infections such as Herpes Simplex virus and Influenza virus and neoplastic disorders or cancer. Advantageously, compositions of the invention inhibit protozoan, virus growth and neoplastic cell proliferation with only minimal or no disruption or ham to the host which may be an animal or human.
    Type: Application
    Filed: June 23, 2010
    Publication date: August 2, 2012
    Applicant: ENTARCO SA
    Inventors: Christine Kritikou, Kevin J. Saliba
  • Publication number: 20120121678
    Abstract: The present invention relates to the vapor-phase application of at least one spinosyn to treat pests including, for example, vadult mosquitoes and houseflies.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 17, 2012
    Applicant: Entarco SA
    Inventor: Christine Kritikou